Utilizing the TIMER2.0 (http://timer.cistrome.org/), UALCAN (https://ualcan.path.uab.edu/), and GEPIA (http://gepia.cancer-pku.cn/) portals, we examined the mRNA expression level of CLDN5 across various cancer types (Fig. 1a). Here, CLDN5 is linked to cancer.